Sunday, February 8, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Loop Capital Maintains Hold Rating on Lowes Companies with Increased Price Target

Elaine Mendonca by Elaine Mendonca
March 12, 2024
in Breaking News
0
Retail Stock Bull Market
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

Analyst Laura Champine of Loop Capital has decided to maintain a Hold rating on Lowe’s Companies (NYSE: LOW) while increasing the price target to $225, up from $220. This adjustment follows a recent decrease in the price target to $210, as Loop Capital expressed concerns about the company’s growth prospects in light of increasing macroeconomic risks. Despite these challenges, the firm believes that higher margins in the near and long term will help offset any declines in revenue following the sale of Lowe’s Canadian business.

Loop Capital also points out that Lowe’s stock may face limitations in terms of potential appreciation due to decreasing same-store sales. However, the firm still views Lowe’s as a more attractive investment compared to Home Depot when considering enterprise value to expected 2024 EBITDA ratios.

Lowes Companies, Inc. (LOW) Stock Price Increases Slightly on March 12, 2024: Stay Informed and Make Informed Investment Decisions

On March 12, 2024, Lowe’s Companies, Inc. (LOW) experienced a slight increase in its stock price. The stock opened at $241.52, which was $0.56 higher than its previous close. Throughout the trading day, LOW shares saw a price increase of $1.63, representing a 0.68% rise in value. Investors should conduct thorough research and analysis before making any investment decisions based solely on short-term price movements. It is crucial for investors to exercise caution and consider their risk tolerance when navigating the stock market. Market conditions can change rapidly, and stock prices can be volatile. Stay informed, stay vigilant, and make informed decisions based on a comprehensive understanding of the market and individual stock performance.

LOW Stock Performance Declines in Latest Financial Report: Revenue Down, Net Income Up, EPS Fluctuates

On March 12, 2024, LOW stock experienced a significant decline in its performance based on the latest financial data provided by CNN Money. The company’s total revenue for the past year was $86.38 billion, which represents an 11.01% decrease compared to the previous year. Additionally, the total revenue for the last quarter was $18.60 billion, showing a 9.13% decrease since the previous quarter.

Despite the decrease in total revenue, LOW managed to increase its net income by 20.73% compared to the previous year, with a net income of $7.75 billion. However, the net income for the last quarter was $1.02 billion, indicating a significant decrease of 42.17% since the previous quarter.

Earnings per share (EPS) for LOW also experienced fluctuations in performance. The EPS for the past year was $13.20, showing a 29.77% increase compared to the previous year. However, the EPS for the last quarter was $1.77, representing a sharp decline of 42.31% since the previous quarter.

Tags: LOW
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
CRWD stock news

The Success Story of Arista Networks A Lucrative Investment Opportunity

Biopharmaceutical Stock Market Today (1)

Analyst Reaffirms Buy Rating on Inozyme Pharma with 23 Price Target

Finance_Investment (2)

Analyzing Options Trading Data for Wells Fargo A Mixture of Bullish and Bearish Sentiments

Recommended

Camping World Stock

Can Camping World Maintain Its Dividend Amid Market Pressures?

5 months ago
Trinity Biotech Stock

Trinity Biotech Faces Critical Nasdaq Compliance Deadline

5 months ago
DVY stock news

Amarin Strengthens Position and Maximizes Shareholder Value Through Share Repurchase Agreement with Cantor Fitzgerald

2 years ago
ASTeMobile Stock

ASTeMobile Shares Face Mounting Pressure as Investor Confidence Wanes

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

Repay Holdings: Annual Report to Test Strategic Refinancing Success

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Trending

Cassava Sciences Stock
Analysis

Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays

by Jackson Burston
February 8, 2026
0

The future of Cassava Sciences appears uncertain following the definitive termination of its Alzheimer's disease program. Detailed...

DroneShield Stock

DroneShield Shares Face Headwinds Despite Record Performance

February 8, 2026
Rock Tech Lithium Stock

Rock Tech Lithium: Investors Await the Final Go-Ahead

February 8, 2026
Puma Biotechnology Stock

Puma Biotechnology Sets Date for Full-Year Financial Disclosure

February 8, 2026
Quanterix Stock

Quanterix Seeks FDA Clearance for Groundbreaking Alzheimer’s Blood Test

February 8, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Cassava Sciences Confirms Alzheimer Drug Failure and Faces Regulatory Delays
  • DroneShield Shares Face Headwinds Despite Record Performance
  • Rock Tech Lithium: Investors Await the Final Go-Ahead

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com